美国预防医学学会:通过预防框架应对阿片类药物流行病
美国预防医学学会(ACPM)阿片类药物工作组运用原始、一级、二级和三级预防框架,梳理当前应对阿片类药物流行的策略并提出推荐,涵盖社会决定因素、处方指南、学校预防、行为健康支持、循证药物治疗、减害服务及去实施策略。
要点
- 原始预防策略包括处理健康社会决定因素和减少不良童年经历。
- 一级预防策略包括支持循证处方指南实施、扩展学校预防项目和改善行为健康支持可及性。
- 二级预防策略包括扩大阿片使用障碍循证药物可及性,尤其是孕妇、住院患者和出狱人群等高危人群。
核心结论
- ACPM运用预防框架识别当前应对阿片类药物流行的策略并提出推荐,涵盖原始、一级、二级和三级预防及去实施策略。
研究设计与样本
- 本文为美国预防医学学会(ACPM)阿片类药物工作组发表的预防框架文章,旨在识别当前策略并提出推荐。
主要发现
- 原始预防策略包括处理健康社会决定因素和减少不良童年经历。
- 一级预防策略包括支持循证处方指南实施、扩展学校预防项目和改善行为健康支持可及性。
- 二级预防策略包括扩大阿片使用障碍循证药物可及性,尤其是孕妇、住院患者和出狱人群等高危人群。
- 三级预防策略包括扩展减害服务,包括扩大纳洛酮可及性和针具交换项目。
- 去实施策略包括减少不适当阿片处方、避免强制性一刀切政策、消除阿片使用障碍药物障碍、破除脱毒作为阿片使用障碍主要单独治疗的迷思以及去污名化照护实践和政策。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The opioid epidemic has resulted in significant morbidity and mortality in the U.S. Health systems, policymakers, payers, and public health have enacted numerous strategies to reduce the harms of opioids, including opioid use disorder (OUD). Much of this implementation has occurred before the development of OUD‒related comparative effectiveness evidence, which would enable an understanding of the benefits and harms of different approaches. This article from the American College of Preventive Medicine (ACPM) uses a prevention framework to identify the current approaches and make recommendations for addressing the opioid epidemic, encompassing strategies across a primordial, primary, secondary, and tertiary prevention approach. Key primordial prevention strategies include addressing social determinants of health and reducing adverse childhood events. Key primary prevention strategies include supporting the implementation of evidence-based prescribing guidelines, expanding school-based prevention programs, and improving access to behavioral health supports. Key secondary prevention strategies include expanding access to evidence-based medications for opioid use disorder, especially for high-risk populations, including pregnant women, hospitalized patients, and people transitioning out of carceral settings. Key tertiary prevention strategies include the expansion of harm reduction services, including expanding naloxone availability and syringe exchange programs. The ACPM Opioid Workgroup also identifies opportunities for de-implementation, in which historical and current practices may be ineffective or causing harm. De-implementation strategies include reducing inappropriate opioid prescribing; avoiding mandatory one-size-fits-all policies; eliminating barriers to medications for OUD, debunking the myth of detoxification as a primary solo treatment for opioid use disorder; and destigmatizing care practices and policies to better treat people with OUD.
引用
- Livingston CJ, Berenji M, Titus TM, et al. American College of Preventive Medicine: Addressing the Opioid Epidemic Through a Prevention Framework. Am J Prev Med. 2022. PMID: 35750550. doi:10.1016/j.amepre.2022.04.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。